Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode 2

May 12, 2025 • 00:42:17

Spyros Papapetropoulos, CEO of Neuphoria

Spyros Papapetropoulos, a leading neurologist and neuroscientist, joins Power CEO, Brandon Li, to discuss his remarkable career and the transformative work at Neuphoria. Spyros...

Episode

September 02, 2025 • 00:45:45

Daniel O'Connell, CEO of Acumen Pharmaceuticals, on Oligomers, Innovation, and Hope in Alzheimer’s

With over 25 years of experience building and investing in CNS companies, Daniel shares the story of why he placed a big bet on...

Episode 13

February 21, 2025 • 01:03:28

Precision Psychiatry and Emerging Technologies

In this episode, Brandon Li sits down with Dr. Jordan Smoller - Jerrold F. Rosenbaum Chair in Psychiatry at Mass General, Co-Director for the...